Tobacco bill passes Senate
This article was originally published in The Tan Sheet
Executive Summary
Branded and generic nicotine replacement therapy products may get quicker routes to market under an amendment to the American Jobs Creation Act of 2004 (HR 4250), which passed the Senate July 15. The amendment, introduced by Sen. Mike DeWine (R-Ohio), would allow FDA regulation of tobacco products and provide a buyout for tobacco farmers. For NRT marketers, the provision advocates the use of time-and-extent applications and other FDA fast-tracking of smoking cessation products, reflecting DeWine's earlier bill (1"The Tan Sheet" May 24, 2004, p. 9)...
You may also be interested in...
FDA tobacco regulation burns out
A provision mandating FDA regulation of tobacco products was struck from the $140 bil. American Jobs Creation Act in the Senate Oct. 6. Co-sponsor Mike DeWine (R-Ohio) called the apparent defeat of the "Youth Smoking Prevention and Public Health Protection Act" a "missed opportunity to pass one of the most important public health provisions that the Congress could ever consider." The FDA regulation bill originally passed the Senate in July (1"The Tan Sheet" July 19, 2004, In Brief)...
Senate Tobacco Bill Advocates Extended Use, New Claims For OTC NRTs
FDA is directed to consider approving extended use of OTC nicotine replacement products in legislation introduced by Sen. Mike DeWine (R-Ohio) and Edward Kennedy (D-Mass.) May 20
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.